4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-038003
Options or other derivatives
- Chief Financial Officer acquired 769,320 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Rawcliffe Adrian Chief Financial Officer | 2019-06-27 | Grant or award · Option to purchase Ordinary Shares | +628,872 | 628,872 | D | ||
| Rawcliffe Adrian Chief Financial Officer | 2019-06-27 | Grant or award · Option to purchase Ordinary Shares | +140,448 | 140,448 | D | ||
Loading xslF345X03/a4.xml…